Table 1 Baseline demographics of 88 asymptomatic carotid stenosis and 81 diabetic nephropathy study subjects.
From: Carotid ultrasound phenotypes in vulnerable populations
| Â | Asymptomatic Stenosis All | Male | Female | Diabetic Nephropathy All | Male | Female |
|---|---|---|---|---|---|---|
Discrete Traits | Â | Â | Â | Â | Â | Â |
No. | 88 | 63 | 24 | 82 | 55 | 27 |
Female | 27.3% | Â | Â | 32.9% | Â | Â |
Current Smoking | 19.3% | 23.4%t | 8.3%t | 13.4% | 16.4% | 7.4% |
Type 1 Diabetes** | 0.0 | 0 | 0 | 17.1% | 14.5% | 22.2% |
Type 2 Diabetes** | 17.0% | 18.8% | 12.5% | 82.9% | 85.5% | 77.8% |
Cholesterol Lowering Treatment n(%) | 80.5 (82) | 83.1 | 73.9 | 70.7 | Â | Â |
Hypertension Treatment n (%) | 92.7 (82) | 91.5 | 95.7 | 98.8 | Â | Â |
≥ 1 Ulceration (%)** | 51.1 | 51.6 | 50.0 | 11.0 | 10.0 | 11.1 |
Quantitative Traits (mean+/- SD | Â | Â | Â | Â | Â | Â |
Age (y)** | 72.8 ± 8.6 | 73.1+/-8.2 | 72.0+/-9.6 | 60.9 ± 11.2 | 61.2+/-11.2 | 60.3+/-11.4 |
BMI (kg/m2)** | 26.4 ± 4.0 (81) | 26.6 +/-3.6 | 26.0+/-5.0 | 33.2 ± 5.9 | 32.6+/-5.6 | 34.3+/- 6.6 |
Total Chol (mmol/L)** | 4.38 ± 0.94 | 4.27+/-0.96 | 4.64+/-0.85 | 4.95 ± 1.56 (80) | 4.65+/-1.34t | 5.57+/-1.81t |
Triglycerides (mM)** | 1.46 ± 0.57 | 1.40+/-0.56 | 1.64+/-0.56 | 2.64 ± 1.81 (78) | 2.43+/-1.36 | 3.06+/-2.47 |
Framingham Score (%)** | 8.3 ± 4.4 | 8.0 +/-4.1 | 9.3+/-5.2 | 19.6 ± 11.4 (78) | 21.3+-12.6t | 16.2+7.9t |
Carotid IMT (mm) | ND | ND | ND | 0.87 ± 0.17 | 0.88+/-0.15 | 0.84+/-0.20 |
Carotid TPA (cm2)** | 3.4 ± 1.8 | 3.8+/-1.8** | 2.4+/-1.5** | 1.3 ± 1.2 | 1.4+/-1.0 | 1.3+/-1.5 |
Carotid TPV (mm3)** | 690 ± 330 | 790+/-330** | 420+/-150** | 160 ± 170 | 180+/-170 | 120+/-150 |